New technologies like wastewater surveillance have enabled public health officials to monitor the spread of a few infectious diseases in a community by identifying known pathogens by their DNA. While ...

PathogenDx, Inc., an innovator in DNA-based pathogen testing technology for cannabis, hemp, agriculture and food safety industries, announced Monday it has secured $7.5 million in Series B funding.

REDWOOD CITY, Calif.--(BUSINESS WIRE)--A pivotal multi-center study published in Clinical Infectious Diseases demonstrates the effectiveness of the Karius Test®, a blood test based on metagenomics ...

PathogenDx, a Scottsdale, AZ tech company that has developed a DNA-based pathogen testing platform, is partnering with Prevenio, a provider of automated food processing and pathogen protection systems ...

PathogenDx's breakthrough technology shifts the pathogen detection paradigm from microbial to molecular testing through its microarray assays, namely DetectX, EnviroX, and QuantX SANTA CLARA, ...

Testing for pathogens is crucial in ensuring the safety of a state's cannabis supply chain. Like any crop, pathogens such as Salmonella and Escherichia coli can infect cannabis plants and pose a ...

PathogenDx, Inc. announced Monday that it raised $7.5 Million in a Series B funding round led by Cresco Capital Partners. The company raised the funds in less than three months with participation from ...

PathogenDx, Inc., an innovator in DNA-based pathogen testing technology for the cannabis, hemp, agriculture and food safety industries, today announced $7.5 million in Series B funding. This latest ...

PathogenDx's Microarray Detection Platform is the fastest and most cost-effective test for UTI detection with higher throughput for efficient and accurate diagnosis. Neeraj Jadhav, Industry Analyst at ...